Biobank for studying pregnancy complications like preeclampsia and preterm birth
Official title: Biobank of Data and of Human Biological Samples on Prematurity, Preeclampsia and Other Pregnancy Complications
Run by CHU de Quebec-Universite Laval · NCT02744365 · Data updated 2026-11-12
This study collects samples and information from pregnant women to see if it can help identify the causes of complications like preeclampsia and preterm birth.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 7845 (estimated) |
| Sponsor | CHU de Quebec-Universite Laval Academic / other |
| Locations | 1 site (Québec) |
| Status | Recruiting |
| Started | April 2015 |
| Main results expected | April 2025 |
| Study ends | April 2028 |
| Registry record updated | March 16, 2022 |
| Trial ID | NCT02744365 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant women who are able to provide informed consent and meet specific inclusion criteria from the original studies.
✕Probably not a fit
Patients who are under 18 years old, have a negative fetal heart rate at recruitment, or cannot provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This biobank collects and stores data and biological samples from women participating in various studies related to pregnancy complications, including preeclampsia and preterm birth. It includes medical, social, obstetrical, and ultrasonographic data, as well as human biological samples such as maternal plasma and cord blood. The goal is to analyze these samples and data to identify risk factors and markers associated with pregnancy complications. This observational approach allows for a comprehensive understanding of the conditions affecting pregnancy outcomes.
Why it matters
Potential benefit: If successful, this biobank could lead to improved prediction and management of pregnancy complications, enhancing maternal and fetal health.
How similar studies have gone: Other studies focusing on biobanks for pregnancy complications have shown promise in identifying risk factors and improving outcomes, suggesting this approach is supported by previous successes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * (specific to each study) Exclusion Criteria: * pregnant women \<18 years old at recruitment * negative fetal heart at recruitment * women not able to provide an informed consent to the study
Where it's running
-
CHU de Quebec
Québec, Canada Recruiting
Study contacts
- Principal investigator: Emmanuel Bujold, MD, MSc — CHU de Quebec
- Study coordinator: Emmanuel Bujold, MD, MSc
- Email: emmanuel.bujold@crchudequebec.ulaval.ca
- Phone: 418-525-4444
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Adverse Pregnancy Outcomes in Uganda through Partnerships and Innovation
This study tests whether everyday health data, ultrasound, and blood samples from first-time pregnant women in Uganda can help predict problems like preeclampsia, fetal growth restriction, and preterm birth.
-
ASPIRE: Predicting Pregnancy Complications Using Blood and Eye Imaging
This study tests whether blood and eye imaging biomarkers can predict conditions like preeclampsia, fetal growth restriction, and gestational diabetes in first-time pregnant people carrying one baby.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Aspirin with or without low‑molecular‑weight heparin to prevent preeclampsia in high‑risk pregnancy
This trial tests whether adding low‑molecular‑weight heparin (tinzaparin) to low‑dose aspirin reduces the chance of preeclampsia in pregnant people identified as high risk in the first trimester.
-
How higher temperatures affect pregnant women and newborns in rural Sindh
This cohort will test whether exposure to high environmental temperatures during pregnancy increases the chances of early birth, low birth weight, or other complications for pregnant women in rural Sindh.
-
Evaluating new ultrasound techniques for assessing placental health
This study is testing new ultrasound techniques to see if they can help tell the difference between healthy pregnancies and those with fetal growth issues.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.